首页> 外文期刊>Jornal Brasileiro de Pneumologia >Drug-resistant tuberculosis in subjects included in the Second National Survey on Antituberculosis Drug Resistance in Porto Alegre, Brazil,
【24h】

Drug-resistant tuberculosis in subjects included in the Second National Survey on Antituberculosis Drug Resistance in Porto Alegre, Brazil,

机译:在巴西阿雷格里港进行的第二次全国抗结核药物耐药性全国调查中,受试者的耐药结核病,

获取原文
       

摘要

OBJECTIVE: To describe the prevalence of multidrug-resistant tuberculosis (MDR-TB) among tuberculosis patients in a major Brazilian city, evaluated via the Second National Survey on Antituberculosis Drug Resistance, as well as the social, demographic, and clinical characteristics of those patients. METHODS: Clinical samples were collected from tuberculosis patients seen between 2006 to 2007 at three hospitals and five primary health care clinics participating in the survey in the city of Porto Alegre, Brazil. The samples were subjected to drug susceptibility testing. The species of mycobacteria was confirmed using biochemical methods. RESULTS: Of the 299 patients included, 221 (73.9%) were men and 77 (27.3%) had a history of tuberculosis. The mean age was 36 years. Of the 252 patients who underwent HIV testing, 66 (26.2%) tested positive. The prevalence of MDR-TB in the sample as a whole was 4.7% (95% CI: 2.3-7.1), whereas it was 2.2% (95% CI: 0.3-4.2) among the new cases of tuberculosis and 12.0% (95% CI: 4.5-19.5) among the patients with a history of tuberculosis treatment. The multivariate analysis showed that a history of tuberculosis and a longer time to diagnosis were both associated with MDR-TB. CONCLUSIONS: If our results are corroborated by other studies conducted in Brazil, a history of tuberculosis treatment and a longer time to diagnosis could be used as predictors of MDR-TB.
机译:目的:描述通过第二次全国抗结核药物耐药性全国调查进行评估的巴西某主要城市的耐多药结核病(MDR-TB)患病率,以及这些患者的社会,人口统计学和临床​​特征。方法:从2006年至2007年在巴西阿雷格里港市参加调查的三家医院和五家初级卫生保健诊所收集的结核病患者中收集临床样本。对样品进行药物敏感性测试。分枝杆菌的种类使用生化方法确认。结果:包括299名患者中,有221名(73.9%)为男性,有77名(27.3%)有结核病史。平均年龄为36岁。在252位接受HIV检测的患者中,有66位(占26.2%)检测为阳性。整个样本中的耐多药结核病患病率为4.7%(95%CI:2.3-7.1),而在新的结核病例中为2.2%(95%CI:0.3-4.2)和12.0%(95) %CI:4.5-19.5)有结核病治疗史的患者。多元分析表明,结核病史和较长的诊断时间均与耐多药结核有关。结论:如果我们在巴西进行的其他研究证实了我们的结果,那么结核病的治疗史和更长的诊断时间可以作为耐多药结核病的预测指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号